Related Experiment Video

Updated: Jun 21, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
12:27

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Published on: May 7, 2015

[Blood coagulation factor levels in candidates for liver transplantation: correlation with disease severity]

Alvaro Giráldez Gallego1, José Manuel Sousa, Juan Manuel Pascasio

  • 1Hospital Universitario Virgen del Rocío, Sección de Hepatología, Sevilla, España. giraldezg@hotmail.com

Gastroenterologia Y Hepatologia
|July 15, 2009
PubMed

Insights

Reduced blood clotting factors II, V, VII, IX, and X correlate with liver disease severity in cirrhosis patients awaiting liver transplantation, aiding in transplant evaluation.

Area of Science:

  • Hepatology and Coagulation Science
  • Biochemistry of Liver Disease

Context:

  • Liver cirrhosis significantly impairs synthetic function, affecting coagulation factor production.
  • Assessing disease severity is crucial for managing patients and determining liver transplantation eligibility.

Purpose:

  • To investigate the relationship between specific blood coagulation factor levels and the severity of liver disease in cirrhotic patients.
  • To determine if coagulation factor deficiencies correlate with established severity scores like Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD).

Summary:

  • This study analyzed coagulation factor levels (II, V, VII, VIII, IX, X) in 87 cirrhotic patients.
  • Reduced levels of factors II, V, VII, IX, and X were observed, particularly in advanced CTP class C.
  • A significant inverse correlation was found between MELD scores and factors II, V, VII, IX, and X.

Impact:

  • Findings highlight the utility of specific coagulation factors as biomarkers for liver disease severity.
  • This correlation can refine the assessment of cirrhotic patients, particularly those considered for liver transplantation.
  • Understanding these relationships may inform clinical decision-making and patient management strategies.
Abstract

More Related Videos

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...